Tradable
BostonS 2,65% 01/06/2030
106.458 i %
0.0545%
BID106.32100 000
ASK106.65100 000
SPREAD
RELATIVE0.3%
ABSOLUTE33
YTM1.9107%
THRESHOLDS105.394 / 107.522
27/10/2020 15:46:21

US101137BA41Corporate BostonS 2,65% 01/06/2030

Display:
No prices history available for now

Market

Price Information
Last price106.458 i %Change prev. closing price0.0580.0545%
Volume-Prev. closing price106.4 vp %
Performance
Daily high106.4652 weeks high107.655
Daily low106.45852 weeks low105.943
Yield to maturity1.9107%YTD- / -
Order book
Intraday
Historical closing prices
Bid
Quantity
Price
100 000
106.32
Ask
Price
Quantity
106.65
100 000

Reference data

Issuer

Issuer
BOSTON SCIENTIFIC CORPORATION
Issuer type
Corporate
Subtype
Health Care
Issuer country
United States of America

Security

ISIN
US101137BA41
Security
BostonS 2,65% 01/06/2030
Coupon
2.65
Maturity
01/06/2030
Redemption price
100
Coupon type
Fixed rate
Coupon periodicity
Half-Yearly
Currency
USD
Issued amount
1 200 000 000
S&P rating
BBB-
Date of admission to trading
17/09/2020

Trading

Market
EMTF
Trade Indicator
%
Interest quoting convention
Clean
Mininum trading amount
2,000
Trading lot
1 000
Prime Liquidity Provider
EUWAX Aktiengesellschaft
Unlisted
Admitted to trading without the consent of the issuer
Admitted to trading venue
Börse Stuttgart
MIC
STUB
Country
Germany
Disclaimer

The information and data (collectively the Information) displayed on this page are made available for general information purposes only. The Information displayed on this page corresponds to the Information officially disclosed and published on LuxSE’s website (www.bourse.lu). In case of any discrepancy between the Information displayed on this page and the Information made available on LuxSE’s website, the latter shall prevail.
LuxSE cannot represent or warrant that the Information will be updated, displayed or made available in real time and/ or without any delay.

The securities mentioned on this webpage are admitted to trading without being admitted to Luxembourg Stock Exchange's (LuxSE) official list (listing) in accordance with sections 503 or 603 of LuxSE Rules & Regulations. These securities have been admitted to trading without the consent of their issuer. The information and data (if any) displayed on this page (collectively the Information) are made available for general information purposes. The Information cannot be disseminated, displayed, sold or distributed, in any manner, in whole or in part, freely or against payment, without LuxSE's prior written consent. The Information is not and shall not be a substitute for your own researches, investigations, verifications, checks or consultation for professional or investment advice. You are using the Information at your own risks.
Although the Information is coming from external sources that are deemed reliable in LuxSE's reasonable opinion, LuxSE does not give any representation or warranty and disclaims any liability or responsibility of any kind in connection with the accuracy, correctness, timeliness, fitness for a particular purpose, reliability or completeness of the Information. LuxSE does not accept any liability or responsibility of any kind for any loss or damages arising directly or indirectly from the use of, or any action refrained or taken on any Information.
The Information does not constitute and is not construed as any advice, solicitation, offer, endorsement, commitment or recommendation on behalf of LuxSE to invest in any financial instrument. Neither does the publication of the Information by LuxSE represent or constitute any warranty or representation from LuxSE in connection with the good standing, profitability, suitability or reliability of any financial instrument and/ or of any issuer. LuxSE cannot represent or warrant that the Information will be updated, displayed or made available in real time and/ or without any delay.

LuxXPrime Newsletter

Investing is all about good market insights, analysis and background knowledge.
Sign up to our newsletter and stay up-to-date with latest market news.